Printer Friendly

ARAMED INC. UNITS SEPARATE: WARRANTS EXERCISABLE OCT. 1, 1993

 SAN DIEGO, Sept. 30 /PRNewswire/ -- Aramed Inc. (NASDAQ: ARAMZ) announced today that the Aramed units, which are comprised of shares of Aramed callable common stock and Gensia Inc. (NASDAQ-NMS: GNSA) warrants, will separate on Oct. 1, 1993. Aramed callable common stock will be traded on the NASDAQ National Market System under the symbol ARAM. The Gensia warrants will be traded on the NASDAQ National Market System under the symbol GNSAW, and the common stock of Gensia will continue to be traded on the NASDAQ National Market System under the symbol GNSA.
 Each warrant represents the right to purchase one and one-half shares of Gensia common stock at an exercise price of $27.67 per share (after adjustment for the 3-for-2 stock split in the form of a 50 percent stock dividend distributed on March 2, 1992). The warrants are exercisable at any time from Oct. 1, 1993, through Dec. 31, 1996.
 Aramed is a special purpose corporation, formed to accelerate the discovery, research, and development of certain compounds utilizing Gensia's ARA technology. Aramed has contracted with Gensia to conduct research and development in three program areas, second generation ARAs for use in the intravenous treatment of acute cardiovascular disorders, ARAs for the oral and intravenous treatment of certain seizure disorders, and ARAs and adenosine agonists for the intravenous treatment of acute cerebrovascular disorders. Gensia is a San Diego-based biopharmaceutical company formed to discover, develop, manufacture, and market novel pharmaceutical products for the treatment and diagnosis of human diseases.
 -0- 9/30/93
 /CONTACT: Elizabeth A. Gard, Gensia Inc., 619-546-8300/
 (ARAMZ GNSA)


CO: Aramed Inc.; Gensia Inc. ST: California IN: MTC SU:

MF-LS -- SD001 -- 7259 09/30/93 12:00 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 30, 1993
Words:280
Previous Article:CHAMPION INDUSTRIES COMPLETES ACQUISITION OF DALLAS PRINTING
Next Article:KAISER STOCKHOLDERS APPROVE SALE OF DEPOSITARY SHARES
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters